GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qinghai Spring Medicinal Resources Technology Co Ltd (SHSE:600381) » Definitions » Scaled Net Operating Assets

Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) Scaled Net Operating Assets : 0.81 (As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Qinghai Spring Medicinal Resources Technology Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Qinghai Spring Medicinal Resources Technology Co's operating assets for the quarter that ended in Sep. 2024 was ¥1,060.7 Mil. Qinghai Spring Medicinal Resources Technology Co's operating liabilities for the quarter that ended in Sep. 2024 was ¥47.0 Mil. Qinghai Spring Medicinal Resources Technology Co's Total Assets for the quarter that ended in Jun. 2024 was ¥1,253.7 Mil. Therefore, Qinghai Spring Medicinal Resources Technology Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.81.


Qinghai Spring Medicinal Resources Technology Co Scaled Net Operating Assets Historical Data

The historical data trend for Qinghai Spring Medicinal Resources Technology Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qinghai Spring Medicinal Resources Technology Co Scaled Net Operating Assets Chart

Qinghai Spring Medicinal Resources Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.84 0.77 0.74 0.74 0.71

Qinghai Spring Medicinal Resources Technology Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 0.73 0.79 0.81 0.81

Competitive Comparison of Qinghai Spring Medicinal Resources Technology Co's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Qinghai Spring Medicinal Resources Technology Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qinghai Spring Medicinal Resources Technology Co's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qinghai Spring Medicinal Resources Technology Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Qinghai Spring Medicinal Resources Technology Co's Scaled Net Operating Assets falls into.


;
;

Qinghai Spring Medicinal Resources Technology Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Qinghai Spring Medicinal Resources Technology Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(1186.382-73.335)/1559.229
=0.71

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1359.312 - 172.93
=1186.382

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=91.994 - 9.834 - 8.825
=73.335

Qinghai Spring Medicinal Resources Technology Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2024 )
=(Operating Assets (Q: Sep. 2024 )-Operating Liabilities (Q: Sep. 2024 ))/Total Assets (Q: Jun. 2024 )
=(1060.712-46.992)/1253.654
=0.81

where

Operating Assets(Q: Sep. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1205.121 - 144.409
=1060.712

Operating Liabilities(Q: Sep. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=60.199 - 2.137 - 11.07
=46.992

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qinghai Spring Medicinal Resources Technology Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Qinghai Spring Medicinal Resources Technology Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Qinghai Spring Medicinal Resources Technology Co Business Description

Traded in Other Exchanges
N/A
Address
East New Road 1, Xining Economic and Technological Development Zone, Xining, CHN, 810007
Qinghai Spring Medicinal Resources Technology Co Ltd is a China-based company that principally engaged in the integrated development, utilization, production, sales, and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company's main products are the cordyceps sinensis series products under the Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis, and raw cordyceps sinensis.
Executives
Xiao Rong Director
Lu Yi Ping Director

Qinghai Spring Medicinal Resources Technology Co Headlines

No Headlines